IsoPlexis Obtains $300,000 New Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    55 Whitney Ave. 2nd Floor New Haven, CT 06520 USA
  • Company Description
    Our proprietary single-cell multiplexing micro-immunoassay and software enable new therapeutic and diagnostic discovery opportunities. Single cell analysis facilitates determination of cellular subsets among heterogeneous cancer and immune cell populations.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    The funding will help the company conduct engineering and software updates, finalize a beta version of its product, and support additional hospital and clinical case studies. It will also go toward product development and working capital.
  • M&A Terms
  • Venture Investor